Researchers are excited about the medication , a groundbreaking dual agonist showing significant data in initial trials for size loss . It acts by targeting two systems: GLP-1 and GIP, which , when https://jasonmqzs764720.angelinsblog.com/39624380/this-new-hope-for-weight-management